ICD-10-CM Billable Code

Z86.00A

Personal history of in-situ neoplasm of the fallopian tube(s)

Clinical Classification Guidelines

Medical Intelligence & Overview

The ICD-10 code Z86.00A refers to a personal history of an in-situ neoplasm of the fallopian tube(s). This code indicates that an individual previously experienced a non-invasive cancerous growth (neoplasm) located in the fallopian tubes, but it has not yet invaded deeper tissues. This history is vital for medical records, ongoing monitoring, and future health planning. Understanding this condition helps explain the importance of regular medical checkups and awareness of potential health implications.

Causes & Symptoms

Clinical Causes: Genetic factors that increase the risk of developing neoplasms Environmental exposures, such as certain chemicals or carcinogens Hormonal influences that may promote abnormal cell growth in reproductive organs Previous radiation therapy or treatments that could lead to cellular changes Underlying genetic syndromes linked to increased susceptibility to gynecological cancers

Key Symptoms: Often no symptoms are present in the early stages of in-situ neoplasms Pelvic discomfort or pain in some cases Unusual vaginal bleeding or discharge Abnormalities detected during routine pelvic exams or imaging Possible detection through follow-up screenings after initial diagnosis or treatment

Diagnostic & Treatment

Diagnosis Path: • Additional tests like hysteroscopy or laparoscopy may assist in visual assessment and tissue sampling

Treatment Protocols: • Patient education and counseling about symptoms and ongoing health surveillance

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is Z86.00A a billable ICD-10 code?
Yes, Z86.00A is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report Z86.00A?
Clinical documentation must specify the nature of Personal history of in-situ neoplasm of the fallopian tube(s) and any associated comorbidities for accurate reporting.

Cite this Clinical Reference